Applied Therapeutics’ (APLT) Outperform Rating Reaffirmed at Leerink Partnrs

Applied Therapeutics (NASDAQ:APLT – Get Free Report)‘s stock had its “outperform” rating reaffirmed by research analysts at Leerink Partnrs in a research note issued to investors on Thursday, PriceTargets.com reports. A number of other analysts have also commented on APLT. SVB Leerink initiated coverage on Applied Therapeutics in a research note on Thursday. They issued […]

Leave a Reply

Your email address will not be published.

Previous post Ineos Unveils All-Electric Fusilier: A Green Addition to the 4×4 Line-up
Next post Envestnet Portfolio Solutions Inc. Takes $1.15 Million Position in Schwab Short-Term U.S. Treasury ETF (NYSEARCA:SCHO)